—
C+
C+ The full Closelook — membership. Open the C+ overview

Thermo Fisher Scientific Inc (TMO) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Thermo Fisher Scientific Inc

TMO in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Thermo Fisher Scientific supplies the instruments, reagents, consumables and services that laboratories use to run life-science research, diagnostics and drug manufacturing. It works through four segments: life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products with biopharma services. Customers include drugmakers, hospitals, academic labs and government researchers. It is based in Waltham, Massachusetts.
Where it sits in the stack
Thermo Fisher sits outside our index seats; it belongs to the healthcare and life-sciences tools sleeve of our universe rather than to a build-out layer such as chips or data centres. It is a supplier of laboratory equipment and reagents to biotech and diagnostics customers, not a constituent of the AI stack the diary tracks elsewhere.
Who it is priced against
Closelook has not placed it in a peer group; the name the market most often compares it with is Danaher, which spans similar life-sciences and diagnostics instrumentation.
Why Closelook tracks it
It carries an S&P 500 seat but no Rubin or Halo placement, and it does not yet carry a Closelook score; the readings the diary notes are a chart move above its 50- and 200-day levels and a broker downgrade to Underperform.
What the diary watches
Whether the downgrade marks a shift in how the market prices its diagnostics and instruments demand, or proves a single call against a steady chart trend.

Thermo Fisher Scientific Inc (TMO) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: TMO news on the tape · index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for TMO, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 2 analyst actions on the wire · latest: downgrade by Citigroup, 2026-09-09

The Street on this name

Analyst actions and the latest print for TMO from the Closelook wires — third-party opinions on the record, not our readings.

  • Downgrade Citigroup — Buy → Underperform Downgraded to Underperform from Buy 2026-09-09
  • Price target UBS — target 730 Target set to $730 (+21.1% to spot) 2026-09-08

2 actions on the analyst wire since 2026-08-13: 1 downgrade, 1 target change. Analyst wire → · Earnings wire →

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against TMO on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 0.28%, quarterly · last 0.47 USD on 2026-09-15

Dividends and capital return

What TMO pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 1.84 USD per share · a 0.28% yield on the 2026-09-17 close 4 distributions, paid quarterly 2026-09-17
  • Change on the year +9.5% against the prior twelve months prior twelve months 1.68 USD per share
  • Last distribution 0.47 USD per share as the price series records it, within days of the ex-date 2026-09-15
  • By calendar year 2024: 0.39 USD (partial) · 2025: 1.72 USD · 2026: 1.41 USD to date first distribution recorded in the three-year window: 2024-12-13

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Thermo Fisher Scientific Inc (TMO)?

Thermo Fisher Scientific Inc trades as TMO on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is TMO in a Closelook index?

Not currently — Thermo Fisher Scientific Inc is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does TMO trade against its moving averages?

Uptrend stack intact: Trades +11.9% vs the 50-day and +22.5% vs the 200-day average, 0.8% below the 52-week high and +51.2% off the 52-week low; a golden cross printed 22 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Thermo Fisher Scientific Inc do?

Thermo Fisher Scientific supplies the instruments, reagents, consumables and services that laboratories use to run life-science research, diagnostics and drug manufacturing. It works through four segments: life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products with biopharma services. Customers include drugmakers, hospitals, academic labs and government researchers. Closelook has not placed it in a peer group; the name the market most often compares it with is Danaher, which spans similar life-sciences and diagnostics instrumentation.

Where does Thermo Fisher Scientific Inc sit in the AI build-out?

Thermo Fisher sits outside our index seats; it belongs to the healthcare and life-sciences tools sleeve of our universe rather than to a build-out layer such as chips or data centres. It is a supplier of laboratory equipment and reagents to biotech and diagnostics customers, not a constituent of the AI stack the diary tracks elsewhere. It carries an S&P 500 seat but no Rubin or Halo placement, and it does not yet carry a Closelook score; the readings the diary notes are a chart move above its 50- and 200-day levels and a broker downgrade to Underperform.

Does Thermo Fisher Scientific Inc pay a dividend?

Thermo Fisher Scientific Inc has paid 1.84 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.28% on the 2026-09-17 close; the last distribution recorded in the price series was 0.47 USD on 2026-09-15. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Thermo Fisher Scientific Inc recently?

The most recent analyst action on Thermo Fisher Scientific Inc on the Closelook wire is a downgrade by Citigroup on 2026-09-09 (Buy → Underperform). 2 actions on the analyst wire since 2026-08-13: 1 downgrade, 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for TMO, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Diagnostics & Research. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.